| 1. |
|
|
| 2. |
|
|
| 3. |
- Chi, Jinshu, et al.
(author)
-
The carbon balance of a managed boreal landscape measured from a tall tower in northern Sweden
- 2019
-
In: Agricultural and Forest Meteorology. - : Elsevier BV. - 0168-1923 .- 1873-2240. ; 274, s. 29-41
-
Journal article (peer-reviewed)abstract
- Boreal forests exchange large amounts of carbon dioxide (CO2) with the atmosphere. A managed boreal landscape usually comprises various potential CO2 sinks and sources across forest stands of varying age classes, clear-cut areas, mires, and lakes. Due to this heterogeneity and complexity, large uncertainties exist regarding the net CO2 balance at the landscape scale. In this study, we present the first estimate of the net CO2 exchange over a managed boreal landscape (∼68 km2) in northern Sweden, based on tall tower eddy covariance measurements. Our results suggest that from March 1, 2016 to February 28, 2018, the heterogeneous landscape was a net CO2 sink with a 2-year mean uptake of −87 ± 6 g C m−2 yr−1. Due to an earlier and warmer spring and sunnier autumn, the landscape was a stronger CO2 sink during the first year (−122 ± 8 g C m−2) compared to the second year (−52 ± 9 g C m−2). Footprint analysis shows that 87% of the CO2 flux measurements originated from forests, whereas mires, clear-cuts, lakes, and grassland contributed 11%, 1%, 0.7%, and 0.2%, respectively. Altogether, the CO2 sink strength of the heterogeneous landscape was up to 38% lower compared to the sink strength of a mature stand surrounding the tower. Overall, this study suggests that the managed boreal landscape acted as a CO2 sink and advocates tall tower eddy covariance measurements to improve regional carbon budget estimates.
|
|
| 4. |
- Hansmann, Georg, et al.
(author)
-
2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT
- 2019
-
In: The Journal of Heart and Lung Transplantation. - : Elsevier BV. - 1053-2498. ; 38:9, s. 879-901
-
Research review (peer-reviewed)abstract
- © 2019 The European Pediatric Pulmonary Vascular Disease Network is a registered, non-profit organization that strives to define and develop effective, innovative diagnostic methods and treatment options in all forms of pediatric pulmonary hypertensive vascular disease, including pulmonary hypertension (PH) associated with bronchopulmonary dysplasia, PH associated with congenital heart disease (CHD), persistent PH of the newborn, and related cardiac dysfunction. The executive writing group members conducted searches of the PubMed/MEDLINE bibliographic database (1990–2018) and held face-to-face and web-based meetings. Ten section task forces voted on the updated recommendations, based on the 2016 executive summary. Clinical trials, meta-analyses, guidelines, and other articles that include pediatric data were searched using the term “pulmonary hypertension” and other keywords. Class of recommendation (COR) and level of evidence (LOE) were assigned based on European Society of Cardiology/American Heart Association definitions and on pediatric data only, or on adult studies that included >10% children or studies that enrolled adults with CHD. New definitions by the World Symposium on Pulmonary Hypertension 2018 were included. We generated 10 tables with graded recommendations (COR/LOE). The topics include diagnosis/monitoring, genetics/biomarkers, cardiac catheterization, echocardiography, cardiac magnetic resonance/chest computed tomography, associated forms of PH, intensive care unit/lung transplantation, and treatment of pediatric PH. For the first time, a set of specific recommendations on the management of PH in middle- and low-income regions was developed. Taken together, these executive, up-to-date guidelines provide a specific, comprehensive, detailed but practical framework for the optimal clinical care of children and young adults with PH.
|
|
| 5. |
|
|
